Trial Profile
Study of quercetin supplementation on risk factors for cardiovascular disease, inflammatory biomarkers and oxidative stress and the relationship between physical activity level in women with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Sep 2016
Price :
$35
*
At a glance
- Drugs Quercetin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 03 Oct 2012 New trial record